These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 27637828)
21. Improving Comprehensive Medication Review Acceptance by Using a Standardized Recruitment Script: A Randomized Control Trial. Miguel A; Hall A; Liu W; Garrett J; Ballew A; Yang TH; Segal R J Manag Care Spec Pharm; 2017 Jan; 23(1):13-21. PubMed ID: 28025924 [TBL] [Abstract][Full Text] [Related]
22. Predictors of Nonadherence to Topical Intraocular Pressure Reduction Medications Among Medicare Members: A Claims-Based Retrospective Cohort Study. Sheer R; Bunniran S; Uribe C; Fiscella RG; Patel VD; Chandwani HS J Manag Care Spec Pharm; 2016 Jul; 22(7):808-817a. PubMed ID: 27348282 [TBL] [Abstract][Full Text] [Related]
23. Comparison of statin adherence among beneficiaries in MA-PD plans versus PDPs. Jung K; McBean AM; Kim JA J Manag Care Pharm; 2012 Mar; 18(2):106-15. PubMed ID: 22380470 [TBL] [Abstract][Full Text] [Related]
24. Economic assessment of changes to an existing medication therapy management program of a large regional health plan. Peasah SK; Hammonds T; Liu Y; Campbell V; Manolis C; Good CB J Manag Care Spec Pharm; 2021 Feb; 27(2):147-156. PubMed ID: 33506728 [No Abstract] [Full Text] [Related]
26. How Much Does Medication Nonadherence Cost the Medicare Fee-for-Service Program? Lloyd JT; Maresh S; Powers CA; Shrank WH; Alley DE Med Care; 2019 Mar; 57(3):218-224. PubMed ID: 30676355 [TBL] [Abstract][Full Text] [Related]
27. Estimating the economic impact of blister-packaging on medication adherence and health care costs for a Medicare Advantage health plan. Borrelli EP; Saad P; Barnes N; Dumitru D; Lucaci JD J Manag Care Spec Pharm; 2024 Sep; ():1-13. PubMed ID: 39258999 [TBL] [Abstract][Full Text] [Related]
28. Pharmaceutical Cost-Saving Strategies and their Association with Medication Adherence in a Medicare Supplement Population. Musich S; Cheng Y; Wang SS; Hommer CE; Hawkins K; Yeh CS J Gen Intern Med; 2015 Aug; 30(8):1208-14. PubMed ID: 25666213 [TBL] [Abstract][Full Text] [Related]
29. Adherence to medication under mandatory and voluntary mail benefit designs. Liberman JN; Hutchins DS; Shrank WH; Slezak J; Brennan TA Am J Manag Care; 2011 Jul; 17(7):e260-9. PubMed ID: 21819173 [TBL] [Abstract][Full Text] [Related]
30. Is There a Relationship Between Part D Medication Adherence and Part C Intermediate Outcomes Star Ratings Measures? Ta JT; Erickson SC; Qiu WA; Patel BV J Manag Care Spec Pharm; 2016 Jul; 22(7):787-95. PubMed ID: 27348279 [TBL] [Abstract][Full Text] [Related]
31. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products. Zhang Y; Lave JR; Donohue JM; Fischer MA; Chernew ME; Newhouse JP Med Care; 2010 May; 48(5):409-17. PubMed ID: 20393360 [TBL] [Abstract][Full Text] [Related]
32. Comprehensive Medication Management and Medication Adherence for Chronic Conditions. Brummel A; Carlson AM J Manag Care Spec Pharm; 2016 Jan; 22(1):56-62. PubMed ID: 27015052 [TBL] [Abstract][Full Text] [Related]
33. Effect of multiple pharmacy use on medication adherence and drug-drug interactions in older adults with Medicare Part D. Marcum ZA; Driessen J; Thorpe CT; Gellad WF; Donohue JM J Am Geriatr Soc; 2014 Feb; 62(2):244-52. PubMed ID: 24521363 [TBL] [Abstract][Full Text] [Related]
34. Longitudinal medication adherence group-based trajectories of aging adults in the US: A retrospective analysis using monthly proportion of days covered calculations. Pontinha VM; Patterson JA; Dixon DL; Carroll NV; Mays D; Barnes A; Farris KB; Holdford DA Res Social Adm Pharm; 2024 Mar; 20(3):363-371. PubMed ID: 38176956 [TBL] [Abstract][Full Text] [Related]
35. Geographic variation in medication adherence in commercial and Medicare part D populations. Couto JE; Panchal JM; Lal LS; Bunz TJ; Maesner JE; O'Brien T; Khan T J Manag Care Spec Pharm; 2014 Aug; 20(8):834-42. PubMed ID: 25062077 [TBL] [Abstract][Full Text] [Related]
36. Predictors of medication nonadherence among patients with diabetes in Medicare Part D programs: a retrospective cohort study. Yang Y; Thumula V; Pace PF; Banahan BF; Wilkin NE; Lobb WB Clin Ther; 2009 Oct; 31(10):2178-88; discussion 2150-1. PubMed ID: 19922889 [TBL] [Abstract][Full Text] [Related]
37. Antiparkinson drug use and adherence in medicare part D beneficiaries with Parkinson's disease. Wei YJ; Palumbo FB; Simoni-Wastila L; Shulman LM; Stuart B; Beardsley R; Brown C Clin Ther; 2013 Oct; 35(10):1513-1525.e1. PubMed ID: 24139423 [TBL] [Abstract][Full Text] [Related]
38. Effect of an intervention to increase statin use in medicare members who qualified for a medication therapy management program. Stockl KM; Tjioe D; Gong S; Stroup J; Harada AS; Lew HC J Manag Care Pharm; 2008; 14(6):532-40. PubMed ID: 18693777 [TBL] [Abstract][Full Text] [Related]
39. Health care system-level factors associated with performance on Medicare STAR adherence metrics in a large, integrated delivery system. Schmittdiel JA; Nichols GA; Dyer W; Steiner JF; Karter AJ; Raebel MA Med Care; 2015 Apr; 53(4):332-7. PubMed ID: 25719517 [TBL] [Abstract][Full Text] [Related]
40. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence. Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]